Holen Sie sich die Stockscreener-App
9.68
2.81%
-0.28
Schlusskurs vom Vortag:
$9.96
Offen:
$9.99
24-Stunden-Volumen:
61,134
Relative Volume:
1.03
Marktkapitalisierung:
$251.70M
Einnahmen:
$26.00M
Nettoeinkommen (Verlust:
$-219.71M
KGV:
-0.1944
EPS:
-49.8
Netto-Cashflow:
$-51.37M
1W Leistung:
-9.02%
1M Leistung:
-14.56%
6M Leistung:
-44.62%
1J Leistung:
-39.76%
1-Tages-Spanne:
$9.55
$10.48
1-Wochen-Bereich:
$9.55
$10.74
52-Wochen-Spanne:
$8.46
$26.50
Cartesian Therapeutics Inc Stock (RNAC) Company Profile
Firmenname
Cartesian Therapeutics Inc
Sektor
Branche
Telefon
301-348-8698
Adresse
7495 NEW HORIZON WAY, FREDERICK
Vergleichen Sie RNAC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RNAC
Cartesian Therapeutics Inc
|
9.68 | 255.08M | 26.00M | -219.71M | -51.37M | -49.80 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Cartesian Therapeutics Inc Stock (RNAC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-09 | Eingeleitet | Wedbush | Outperform |
| 2024-12-19 | Eingeleitet | BTIG Research | Buy |
| 2024-08-06 | Eingeleitet | TD Cowen | Buy |
| 2024-07-02 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2024-06-04 | Eingeleitet | Oppenheimer | Outperform |
| 2024-05-24 | Eingeleitet | Mizuho | Buy |
| 2024-04-23 | Bestätigt | H.C. Wainwright | Buy |
| 2024-04-23 | Eingeleitet | Leerink Partners | Outperform |
| 2023-08-18 | Herabstufung | SVB Securities | Outperform → Market Perform |
| 2022-06-14 | Bestätigt | Needham | Buy |
| 2022-06-06 | Eingeleitet | SVB Leerink | Outperform |
| 2021-06-15 | Eingeleitet | BTIG Research | Buy |
| 2021-01-26 | Hochstufung | Mizuho | Neutral → Buy |
| 2020-10-01 | Herabstufung | Mizuho | Buy → Neutral |
| 2020-10-01 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2020-06-12 | Herabstufung | Stifel | Buy → Hold |
| 2020-04-28 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-01-29 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-01-21 | Eingeleitet | William Blair | Outperform |
| 2018-06-27 | Eingeleitet | Janney | Buy |
| 2017-03-30 | Bestätigt | UBS | Buy |
Alle ansehen
Cartesian Therapeutics Inc Aktie (RNAC) Neueste Nachrichten
Is Cartesian Therapeutics Inc. stock poised for growthEntry Point & Expert Curated Trade Setup Alerts - Newser
Best data tools to analyze Cartesian Therapeutics Inc. stockMarket Movers & AI Driven Stock Reports - Newser
Why Cartesian Therapeutics Inc. stock could rally in 2025Market Trend Report & Smart Money Movement Tracker - baoquankhu1.vn
Is Cartesian Therapeutics Inc. reversing from oversold territoryJuly 2025 Retail & Weekly Momentum Picks - Newser
Sector ETF performance correlation with Cartesian Therapeutics Inc.Portfolio Growth Summary & High Accuracy Buy Signal Tips - Newser
What candlestick patterns are forming on Cartesian Therapeutics Inc.Weekly Market Outlook & Technical Confirmation Trade Alerts - Newser
Custom watchlist performance reports with Cartesian Therapeutics Inc.Quarterly Earnings Report & Risk Managed Investment Strategies - Newser
Candlestick signals on Cartesian Therapeutics Inc. stock todayCEO Change & Consistent Growth Equity Picks - Newser
How moving averages guide Cartesian Therapeutics Inc. tradingEarnings Growth Report & Community Verified Swing Trade Signals - Newser
Short interest data insights for Cartesian Therapeutics Inc.July 2025 Momentum & Safe Investment Capital Preservation Plans - Newser
Is Cartesian Therapeutics Inc. stock bottoming outJuly 2025 Summary & Weekly Stock Performance Updates - Newser
News impact scoring models applied to Cartesian Therapeutics Inc.July 2025 Trade Ideas & Stock Timing and Entry Methods - Newser
What momentum shifts mean for Cartesian Therapeutics Inc.July 2025 Momentum & Short-Term Swing Trade Alerts - Newser
Can you recover from losses in Cartesian Therapeutics Inc.Market Activity Recap & Verified Entry Point Signals - Newser
Is Cartesian Therapeutics Inc. showing signs of accumulationPortfolio Return Summary & Low Risk Investment Opportunities - Newser
Can Cartesian Therapeutics Inc. rally from current levels2025 Big Picture & Reliable Intraday Trade Plans - Newser
Combining machine learning predictions for Cartesian Therapeutics Inc.Portfolio Return Summary & Expert-Curated Trade Recommendations - Newser
Published on: 2025-09-11 11:55:35 - Newser
27,869 Shares in Cartesian Therapeutics, Inc. $RNAC Bought by Nuveen LLC - MarketBeat
What’s next for Cartesian Therapeutics Inc. stock priceJuly 2025 Analyst Calls & Free Fast Gain Swing Trade Alerts - Newser
Measuring Cartesian Therapeutics Inc.’s beta against major indicesJuly 2025 Spike Watch & Community Consensus Trade Signals - Newser
Published on: 2025-09-10 04:20:46 - Newser
Using economic indicators to assess Cartesian Therapeutics Inc. potentialDay Trade & Real-Time Price Movement Reports - Newser
Predicting Cartesian Therapeutics Inc. trend using moving averages2025 Top Decliners & Free High Return Stock Watch Alerts - Newser
Will Cartesian Therapeutics Inc. continue its uptrendPrice Action & Daily Stock Momentum Reports - Newser
Is Cartesian Therapeutics Inc. a defensive stockMarket Volume Report & Weekly Watchlist for Hot Stocks - Lancaster City Council
What technical models suggest about Cartesian Therapeutics Inc.’s comebackTrend Reversal & Daily Volume Surge Signals - Newser
Cartesian Therapeutics Inc. stock outlook for YEARQuarterly Portfolio Report & Consistent Return Strategy Ideas - Newser
Cartesian Therapeutics Inc. recovery potential after sell offEarnings Risk Report & Technical Confirmation Alerts - Newser
Is Cartesian Therapeutics Inc. the Top Chart Pick This WeekPortfolio Gains Summary & Growth-Oriented Investment Plans - beatles.ru
cartesian therapeutics inc. stock volume spike explainedJuly 2025 Weekly Recap & Fast Momentum Entry Tips - Newser
Finanzdaten der Cartesian Therapeutics Inc-Aktie (RNAC)
Umsatz
Nettogewinn
Free Cashflow
ENV
Cartesian Therapeutics Inc-Aktie (RNAC) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| English Emily | Chief Operations Officer |
Apr 15 '25 |
Option Exercise |
3.30 |
7,500 |
24,750 |
47,726 |
| SPRINGER TIMOTHY A | Director |
Apr 10 '25 |
Buy |
10.47 |
48,595 |
508,751 |
620,175 |
| SPRINGER TIMOTHY A | Director |
Apr 09 '25 |
Buy |
9.43 |
41,782 |
393,947 |
571,580 |
| SPRINGER TIMOTHY A | Director |
Apr 11 '25 |
Buy |
10.77 |
36,338 |
391,455 |
656,513 |
| SPRINGER TIMOTHY A | Director |
Apr 10 '25 |
Buy |
10.47 |
8,575 |
89,773 |
8,637,273 |
| SPRINGER TIMOTHY A | Director |
Apr 09 '25 |
Buy |
9.43 |
7,373 |
69,517 |
8,628,698 |
| SPRINGER TIMOTHY A | Director |
Apr 11 '25 |
Buy |
10.77 |
6,412 |
69,074 |
8,643,685 |
| SPRINGER TIMOTHY A | Director |
Mar 20 '25 |
Buy |
15.59 |
54,889 |
855,593 |
8,621,325 |
| SPRINGER TIMOTHY A | Director |
Mar 19 '25 |
Buy |
14.97 |
20,234 |
302,962 |
8,566,436 |
| SPRINGER TIMOTHY A | Director |
Mar 18 '25 |
Buy |
14.42 |
14,740 |
212,599 |
8,546,202 |
0.93%
0.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):